CEO and Chairman of the Board
President and Chief Operating Officer
Chief Commercial Officer
Duncan Fatkin joined AIT as its Chief Commercial Officer in January 2019. Mr. Fatkin has a successful track record in the global medical device and biopharmaceutical industries, building out commercial capabilities, leading marketing and sales teams, and cultivating strong thought leader relationships across multiple specialties. His 25+ years of experience includes, most recently, roles with Becton Dickinson (Worldwide Vice President, Injection, Diabetes Care), Zimmer Biomet (Vice President and General Manager, Office Based Technologies), Smith & Nephew/Bioventus (Vice President, Global Marketing & Reimbursement) and DePuy/Johnson & Johnson (Worldwide Vice President, iOrthopaedics). Mr. Fatkin has spent more than 10 years of his career in both Europe and the Asia Pacific region, with the last 9+ years in the United States. He received his Bachelor of Arts degree in Materials Science from Oxford University and his Diploma in Marketing from Thames Valley University. He has been a Chartered Marketer and Member of the Chartered Institute of Marketing for almost 30 years.
Giora Davidai, MD
Chief Medical Officer
Douglas Beck, CPA
Chief Financial Officer
Vice President of Regulatory Affairs
Douglas Beck, CPA joined AIT as its Chief Financial Officer in November 2018. Mr. Beck has been a Chief Financial Officer for five public companies, three of which were biotechnology companies. Mr. Beck has assisted companies’ raising equity and debt in excess of $100 million. He spent over four years at Lev Pharmaceutical, Inc. until the completion of a $618 million sale of the company. Mr. Beck serves on the New York State Society of CPAs Chief Financial Officer and SEC committee.
Rhona Shanker is the Vice President of Regulatory Affairs at AIT. She is a regulatory affairs expert and a former FDA/CDRH/ODE expert regulatory reviewer with an extensive experience in the medical device industry, more than 35 years, where she reviewed over 3,500 applications. Rhona’s professional experience is focused on developing strategies for complying with FDA pre- and post-market regulatory requirements, including: developing regulatory strategies for pre-market submissions, planning IDE, 510(k), PMA, HUD, HDE, and CE projects; preparing 510(k), IDE, PMA, Design Dossiers, and Clinical Evaluation Reports for submission and more. Previously, Rhona held a position of the Expert Regulatory Review Scientist for heart assist devices at the Food and Drug Administration’s Center for Devices and Radiological Health (CDRH), in the Office of Device Evaluation (ODE), Division of Cardiovascular and Respiratory Devices, (DCRD/DCD). Prior to that, she also worked in the positions of Senior Reviewer and Consumer Safety Officer at the FDA. Rhona has been an invited speaker at multiple medical and regulatory affairs affiliated conferences, expositions and webinars. She graduated from Emory University with a degree in Biology and has co-authored several professional publications.